Form 8-K - Current report:
SEC Accession No. 0001193125-25-145767
Filing Date
2025-06-24
Accepted
2025-06-24 16:33:05
Documents
12
Period of Report
2025-06-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d887674d8k.htm   iXBRL 8-K 42518
  Complete submission text file 0001193125-25-145767.txt   154333

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA orgo-20250623.xsd EX-101.SCH 2857
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE orgo-20250623_lab.xml EX-101.LAB 17236
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orgo-20250623_pre.xml EX-101.PRE 10817
15 EXTRACTED XBRL INSTANCE DOCUMENT d887674d8k_htm.xml XML 3530
Mailing Address 85 DAN ROAD CANTON MA 02021
Business Address 85 DAN ROAD CANTON MA 02021 781-575-0775
Organogenesis Holdings Inc. (Filer) CIK: 0001661181 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37906 | Film No.: 251069650
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)